chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fever of 101 degrees Fahrenheit with headache, body aches, fatigue and pain at the injection site.  Systems began 9am 4/9/2021 and subsided 12:00am 4/10/2021
0.25 ml fluviron given.  Vaccine meant for 44 yrs and older.  Warning on box but not on actual vial.  Patient had no reaction.
After first dose I felt an overall odd feeling .     no shortness of breath etc, just odd.    I was thinking it may have been just some anxiety.  I left the center after 15 minutes and came back to Pediatric office where I work.  I did take a Zyrtec and felt completely better after approx. an hour.  After the 2nd dose I did mention I had felt odd after 1st dose and decided to sit for 30 min.  I felt about the same as I did after the 1st dose so I left.  when  I got to my car my face was flushed.  I was not tachycardia just a very odd felling in my head and then my tongue did start to itch (or feel funny)  .  I took a Zyrtec and went home.  I never had any swelling of lips or tongue, no trouble breathing.  Pulse stayed constant around 80.  This time the symptoms lasted approx. 4 hours.  I I did continue to take Zyrtec for 3 days after injection.
This case was reported by a physician via call center representative and described the occurrence of fever in a 59-year-old male patient who received SHINGRIX for prophylaxis. Previously administered products included SHINGRIX. On 11th September 2018, the patient received the 2nd dose of SHINGRIX. On 12th September 2018, 1 days after receiving SHINGRIX, the patient experienced fever. On an unknown date, the outcome of the fever was unknown. It was unknown if the reporter considered the fever to be related to SHINGRIX. Additional details were provided as follows: The patient who was also a healthcare professional reported experiencing a fever of 101.2 degrees. This case has been linked to the US2018GSK172085, reported by the same reporter. The reporter was already stated that, healthcare professional experienced fever with first dose and stated that he previously reported the adverse event for the first dose of SHINGRIX, but no case was found, so created case US2018GSK172085.
Patient received Shingrix #2 around 11/10/2021 and began to experience vertigo the second day after the vaccine.
Missed dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed dose) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   No treatment information was provided.  Additionally it was reported that patient missed the second dose as vaccination site did not advise the patient of date for second dose.    Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Patient and suspect drug details updated.
PATIENT STATES HE EXPERIENCED ITCHING AT THE INJECTION SITE APPROXIMATELY 9 HOURS AFTER RECEIVING THE VACCINTATION (THE SAME DAY).  THE NEXT MORNING HE HAD REDNESS AROUND THE INJECTION SITE AND REDNESS ON HIS INNER UPPER ARM THAT MOVED DOWN HIS ARM TOWARD HIS ELBOW. THAT AREA WAS WARM TO THE TOUCH AND HAD TWO BLISTER-LIKE AREAS ABOUT THE SIZE OF A QUARTER-DOLAR.  PATIENT TOOK ONE DOSE OF ORAL BENADRYL ANOUT 24 HOURS AFTER HIS INJECTION, AND A SECOND DOSE OF BENADRYL ABOUT 6 HOURS LATER. OUTCOME STILL PENDING.
Information has been received from a pharmacist concerning a 62 year old male who on 1/13/06 was vaccinated intramuscularly in the left deltoid with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649732/0513P). On 1/15/06 the patient was presented to the ER and diagnosed with cellulitis. The patient was treated with Ibuprofen Motrin and released. The patients present status was reported as unknown. The pharmacist is requesting a lot check. The patient's experience was considered to be an important medical event by the reporter (OMIC). The records of testing prior to release of this lot have been checked and found to be satisfactory. The lot complies with the standards and was released. Additional information has been requested.
6/26 pt c/o redness, approx 1/4-1/2" at site and tenderness. Small papule noted w/ yellow bead present. 6/28 area of redness decreased no tenderness.
Swelling on the right side of my neck, face, and eyes Rash on both arms, neck, leg, thigh, and lower back  I was prescribed Prednisone 20 mg, Methylprednisolone, and Zyrtec.
mild side effects; This case was reported by a consumer and described the occurrence of adverse drug reaction in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix and had mild side effect symptoms. The reporter asked was it ok for me to be around a six month old baby after my second shingrix shot.
hives, itching pt called to clinic;told to take DPH & call clinic back if no improvement;
This patient received two doses of the pediatric hepatitis B vaccine within 24 hours. The patient received the first dose shortly after birth and the second upon arrival to the NICU at a second facility in the organization. The MAR from the previous facility was not reviewed thoroughly. No adverse reactions were noted.
The adverse side effect being experienced is a change in menstrual cycle length and flow. This is a noticeable change as my cycle has been very consistent for over 20 years. My menstrual cycle is not longer and heavier than previously experienced.  The difference began after my first dose and has not yet resolved.  I was told by health care professionals that it should resolve within a few months, but this has not happened thus far. I am now approximately 8 months post booster vaccination and there is still no return to my previous menstrual cycle pattern.
Burning in the arm for three hours, relived it with ibuprofen & ice pack. Fatigued and light headedness for the first 3 days.  All my joints ached and had a Headache and upset stomach for 7-10 days. Migraines started after 10 days, along with  extreme pain in the bottom of my feet. After 6 months I still have a gnawing pain in my feet , muscles weakness and different joints  aching .
Excess fatigue.  Heavy periods after absence of period.  Joint pain.  Sensitivity to light (continued 3 mos).
03/17/2023 I started having   what I thought were COVID-19 symptoms and was sore all over. My left foot was swollen, red and hot to touch. I was sick for 3 days prior to contacting my PCP, I was seen at the hospital and was admitted for Cellulitis and put on antibiotics for 5 days. I was given a Diagnostic ultrasound of my leg to rule out blood clots and it was clear. Xray showed that I also have arthritis in both feet. The pain in in my leg has improved but the swelling has not subsided at this time.
Developed Urticaria; This spontaneous case was reported by an other health care professional and describes the occurrence of INJECTION SITE URTICARIA (Developed Urticaria) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.   No Medical History was provided by the reporter. Concurrent medical conditions included Penicillin allergy.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced INJECTION SITE URTICARIA (Developed Urticaria). At the time of the report, INJECTION SITE URTICARIA (Developed Urticaria) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Painful lesion left eye, redness. Treatment acyclovir. Pt. saw ophthalmology 2-25-13, no ocular findings.
Pain in her finger, in the muscles and bone and finger joint; Pain in her finger, in the muscles and bone and finger joint; Pain in her finger, in the muscles and bone and finger joint; Pain in her finger, in the muscles and bone and finger joint; This is a spontaneous report from a contactable consumer (patient). A 63-year-old female patient received second dose of bnt162b2 (BNT162B2, solution for injection, Lot Number: EL9269, Expiry Date: Unknown), dose 2 via an unspecified route of administration on 09Feb2021 (at the age of 63-year-old) as dose 2, single for COVID-19 immunisation. Medical history included thyroid for many years. Concomitant medication(s) included trazodone and melatonin taken for thyroid from an unspecified date. The patient's historical vaccine included first dose of bnt162b2 (BNT162B2, solution for injection, Lot Number: EL3747 or it could be EV3747, Expiry Date: Unknown), dose 1 via an unspecified route of administration on 19Jan2021, as dose 1, single for COVID-19 immunisation. The patient experienced pain in her finger, in the muscles and bone and finger joint on an unspecified date. Patient was called about the Pfizer Corona virus vaccine. She obviously has something, in the bone sometimes and sometimes in the muscle it is painful, it is a pain that never happened before, so she thinks the vaccine is the reason, but the pain is very soon and sudden and then it is gone. it is in the bone and muscles in her finger, in the bone and it is painful. It comes very fast and then it is gone. Sometimes she sits down for a while and the pain comes and then it's gone comes on soon and is fast to disappear. She stated weighs more now she has gained 10 pounds, she has never had such weight, never. The pain is in the muscles, and it is gone fast, a sudden pain and then it's gone, it is in her finger. She clarifies it is in the joint, the finger. It happens more often, it happens every day, she did not pay attention to when it started, it just got her attention, it is painful in the joint. She clarifies she does not know when it started but it happens every day. She asked does she need to make a blood test to see anything gas changed or something like that. The patient underwent lab tests and procedures which included weight: 105 or 107 on an unspecified date, (before she weighed 105 or 107 now, she weighs 116 or 117) and weight: 116 or 117 on an unspecified date. (Increase- before she weighed 105 or 107 now, she weighs 116 or 117). The clinical outcome of the events was reported as not recovered.  No follow-up attempts are needed. No further information is expected.
cold; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 22Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NASOPHARYNGITIS (non-serious) with onset 2021, outcome "unknown", described as "cold".  Additional information: The patient had the first dose on 22Apr2021 and scheduled to have her second dose this coming Friday on 14May2021. The patient had colds.  wants to know if it is okay to get the second dose even if she has a cold.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax 21JUL97 pt @ home started afternoon, evening, noc, irritable, uncomfortable, persistent crying, t102;MD reports child had mild rxn to tetramune;
Dehydration s/s of sepsis, multiple electrolyte abnormalities, aggressive supportive case with fluid, broad spectrum antibiotics, anti fungal, pressure. Infectious work up, Hepatitis, Ricketts, Influenza, Blood culture x 4ct, Typhoid fever, Poly Mt spotted fever, EMV, Epstein Barr were reg diagnosis, react to yellow fever vaccination or Blood work sepsis or viral sepsis from a unk agent, slow steady improvement. Discharge Diagnosis: Sepsis syndrome, Anemia, Hypotension, Respiratory Insufficiency, Multiple electrolyte abnormalities, transaminitis, Pancytopenia, Renal Insufficiency, Metabolic acidosis, admitted 11/8/04, discharged 11/18/04.
HE received Moderna COVID-19 vaccine at outside on 1/13/21 and 2/8/21 he noticed left sided tinnitus within a week after the second dose of Moderna COVID-19 vaccine.  However, he didn't report till in April at office visit time when the tinnitus was persistent.  He had prior history of tinnitus but this time was more intense. He took OTC Silancin and felt better but not completely resolved.
His head is hurting so bad to the point where he can't lay down; Diarrhea; Fever; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (His head is hurting so bad to the point where he can't lay down), DIARRHOEA (Diarrhea), PYREXIA (Fever) and NAUSEA (Nausea) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (His head is hurting so bad to the point where he can't lay down), DIARRHOEA (Diarrhea), PYREXIA (Fever) and NAUSEA (Nausea). At the time of the report, HEAD DISCOMFORT (His head is hurting so bad to the point where he can't lay down), DIARRHOEA (Diarrhea), PYREXIA (Fever) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.
She got her vaccine at the nursing home, four days later in the morning at 6:00 AM her granddaughter received a call from nursing home that she was having a heart attack.  They gave her nitroglycerine and sent her to the hospital.  She then received a call from the surgeon at the hospital that she had a perforation in her stomach, and had to open up her stomach and see what was going and repair the perforation.  During the surgery they found that a bunch of her bowel was septic, she had an abscess inside.  They pulled part of her colon out and sewed her up and gave her a colostomy bag.  Then she had a drain on her and she was intubated as a result of the surgery.  It took her about 3 days to get off of that, and then they were having issues stabilizing her oxygen.  They did some scans of her head and found out that she indeed had several major strokes recently which they previously did not know.  She had a major GI bleed, and then her oxygen saturations was not doing good and she was on an NG tube as she was not taking nutrition.  She was then called that her quality of life was not good and that she was going downhill, they started giving her Morphine and Ativan and on 9/7/22 she died.    She was wheelchair bound prior to the vaccines, was able to write in her journey, very social and could use her phone independently.  She was in an assisted living.  She had the vaccine and then she was not able to write anymore, feed herself anymore as she had a stroke and was never the same after that.     Death certificate reads:  Respiratory failure, perforated abdominal viscus, multiple strokes, atrial fibrillation.   The approximate interval of onset of death was hypoxia.
Rash in her mouth/break out on her lips and her ear; Rash in her mouth/break out on her lips and her ear; Shingles; Pain; Ramsay-Hunt syndrome; Loss of hearing; Itchy on the left side of the face; Blisters on face, temple, ear; Left side of her face is scorched bright red and painful; Left side of her face is scorched bright red and painful; Numbness; no feeling in her mouth on the left, cheek, temple; Numbness; no feeling in her mouth on the left, cheek, temple; Blisters in her mouth; Pain, teeth started hurting went to her temple; Pain, teeth started hurting went to her temple; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number and expiration date were not reported) on the left arm on 20Feb2021 (09:30) as a single dose, with route of administration unspecified, for COVID -19 immunization at the pharmacy/drug store (not a military facility). Medical history included shoulder surgery in Aug2020; ongoing abnormal blood pressure; ongoing heart disorder; and was in a pacemaker and defibrillator. Concomitant medications included carvedilol for abnormal blood pressure from 2012 and ongoing; losartan for heart disorder from 2012 and ongoing; and furosemide from 2017 and ongoing. On 05Mar2021, the patient had Ramsay-Hunt syndrome and loss of hearing. On 21Feb2021, the patient had pain/teeth started hurting and went to her temple. On 22Feb2021, the patient had blisters in the mouth; left side of the face was scorched bright red and painful; and numbness/no feeling in the mouth on the left, cheek and temple. On 23Feb2021, the patient had blisters on face, temple and ear. On 25Feb2021, the patient was itchy on the left side of the face. On an unspecified date, the patient had rash in her mouth/broke out on her lips and ear; shingles; and pain. The events, 'pain/teeth started hurting and went to her temple', 'blisters in the mouth', 'blisters on face, temple and ear' and 'pain', had resulted into physician's office visit. The patient's ENT had the patient put on treatment with valaciclovir (VALTREX) and prednisolone for the 'blisters in the mouth', 'blisters on face, temple and ear'; treatment for 'pain/teeth started hurting and went to her temple', 'left side of the face was scorched bright red and painful', 'itchy on the left side of the face', 'rash in her mouth/broke out on her lips and ear', 'shingles' and 'pain'; and unspecified ear drops for 'loss of hearing'. The outcome of the events was not recovered for 'Ramsay-Hunt syndrome', 'loss of hearing', 'pain/teeth started hurting and went to her temple', 'left side of the face was scorched bright red and painful', 'numbness/no feeling in the mouth on the left, cheek and temple' and 'itchy on the left side of the face'; was recovered on 04Mar2021 for 'blisters in the mouth' and 'blisters on face, temple and ear'; and was unknown for 'rash in her mouth/broke out on her lips and ear' and 'pain'. The patient had received the second dose of vaccination on 20Mar2021.  Information about batch/lot number has been requested.
Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Covid-19). At the time of the report, COVID-19 (Covid-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: other positive (Positive) tested positive for Covid-19.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant product was provided. No treatment information was provided.
was admitted for acute hypoxemic respiratory failure secondary to COVID 19 pneumonia , intubated 10/25/21 , not on anticoagulation due to alveolar hemorrhage, HD initiated by nephrology due to worsening renal funciton. ID , nephrology and  pulmonary medicine evaluating , patient was on Cefepime and vancomycin . In course of hospital stay also received  Doxycycline ,  Vancomycin , Remdesivir, Decadron . Clinically , respiratory status did not improve and patient remained on mechanical ventilator . Family decided for comfort care only , patient was extubated and expired 11/08/21 at 8:56 pm.
07 November 2023 influenza vaccine recipient reported she has concerns of shoulder injury related to vaccine administration (SIRVA). She was vaccinated 31 October 2023 with vaccine provided by a work-related occupational health program. She states pain/soreness developed approximately ninety minutes after vaccination. She thought it was typical post vaccination pain/soreness. However, her pain/soreness and now decreased range of motion are causing her concern. She will seek guidance from Healthcare Occupational Health for next steps.
Flush face, hives all over body-itching. Unable to breathe, throat closing up sent to hospital ER 911.
Severe dizziness soon after the shot was administered, the shot was administered was given approximately 10:30 a.m. I am going to see my neurologist. I have epilepsy and so thinking maybe it was something with that but now realized it could have been with the shot. This is my second day and still having dizziness.
J96.00 ACUTE RESPIRATORY FAILURE 9/14/2022 SEPTIC SHOCK
This spontaneous report as received from a registered nurse refers to a female kindergarten student. The patient was vaccinated subcutaneously with VARIVAX (lot# unspecified) in July-2012, "about two weeks ago". The reporter did not know if the was the first or second dose of VARIVAX (merck) that the patient had been administered. On an unknown date, after being administered this dose of VARIVAX (merck), the patient developed chickenpox. The outcome of patient was reported as not recovered/not resolved. The patient sought medical attention at a physician's office. Additional information is not expected.
On day of injection: axillary tenderness, resolved. 1 week after injection (1/7/21): redness, swelling, and warmth over site of injection, ongoing